Publication date: Jun 01, 2026
We present a retrospective analysis of our experience managing pediatric empyema, focusing on clinical, microbiological, radiological aspects, surgical and fibrinolytic outcomes over an 8-year period, encompassing the 2022-2023 United Kingdom invasive group A Streptococcus (iGAS) surge. This observational study aimed to test the hypothesis that the post-pandemic period has revealed a new pattern of microbes, disease patterns, and treatment effectiveness. Case notes of children (
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Empyema |
| disease | MESH | COVID-19 |
| disease | MESH | Empyema Pleural |
| disease | MESH | Streptococcal Infections |
Original Article
(Visited 4 times, 1 visits today)